American Rebel Holdings Inc
Change company Symbol lookup
Select an option...
AREB American Rebel Holdings Inc
VTN Invesco Trust for New York Investment Grade Municipals
VVR Invesco Senior Income Trust
CLX Clorox Co
SNCY Sun Country Airlines Holdings Inc
NCZ Virtus Convertible & Income Fund II
XPEV Xpeng Inc
PTON Peloton Interactive Inc
PEB Pebblebrook Hotel Trust
VFC VF Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Industrials : Commercial Services & Supplies | Small Cap Value
Company profile

American Rebel Holdings, Inc. operates primarily as a designer and marketer of branded safes and personal security and self-defense products. The Company designs and produces branded accessories and apparel, including concealment pockets. It offers an assortment of personal security products, as well as apparel and accessories for men and women under the Company’s American Rebel brand. Its products are designed to store firearms, as well as store its customers’ keepsakes, family heirlooms and treasured memories. It offers a range of concealed carry jackets, vests and coats for men and women. The Company’s apparel collection consists of Cartwright Coats and Vests, Freedom 2.0 Jackets and Vests and American Rebel T-Shirts Collection. Its safe collection consists of six safes in a range of sizes: AR-50, AR-40, AR-30, AR-20, AR-15 and AR-12. The Company is also a manufacturer of gun safes with security and fire protection.

Closing Price
$0.2459
Day's Change
0.0006 (0.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2575
Day's Low
0.2311
Volume
(Light)
Volume:
1,144,009

10-day average volume:
1,747,588
1,144,009

Zentek Provides Update on HVAC Testing

8:01 am ET September 15, 2022 (Accesswire) Print

GUELPH, ON / ACCESSWIRE / September 15, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada ("ISC") Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne test organisms without modification to existing HVAC systems, (ii) no reduction in air flow rates, and (iii) no significant shedding of the ZenGUARDT coating. ZenGUARDT-coated HVAC filters demonstrated a maximum improvement of 99% compared to equivalent MERV-rated uncoated filters using a bacteriophage (a SARS-COV-2 surrogate).

"The significant increase in filtration efficiency of pathogen-laden water droplets, without an impact to airflow rates, creates a potentially powerful solution in the HVAC space," said Greg Fenton, CEO of Zentek. "Working with current systems, and not requiring additional energy or changes to existing equipment, our technology could be a simple and energy-efficient approach to providing cleaner air for indoor spaces and is highly supportive of current global indoor air quality initiatives."

Phase 1 testing was conducted by CremCo Laboratories with assistance by the Aerospace Research Centre, a department of the National Research Council of Canada. Zentek is now in Phase 2 Testing at the National Research Council to demonstrate a reduction in live airborne surrogate contamination within a modular classroom environment, simulating a real-world environment. The Company will report results when completed and validated.

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.

Zentek's proprietary ZenGUARDT coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARDT production facility is located in Guelph, Ontario.

For further information:

Tyler Dunnâ?¯

Tel: (306) 717-6745â?¯

Email: tdunn@zentek.com

To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR profile at http://www.sedar.com/.

Forward-Looking Statementsâ?¯

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.â?¯

SOURCE: Zentek Ltd.





View source version on accesswire.com:

https://www.accesswire.com/716072/Zentek-Provides-Update-on-HVAC-Testing



comtex tracking

COMTEX_414484960/2457/2022-09-15T08:01:52

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.